Details

Autor(en) / Beteiligte

• Schlager, Oliver
• Giurgea, Aura
• Schuhfried, Othmar
• Seidinger, Daniela
• Hammer, Alexandra
• Gröger, Marion
• Fialka-Moser, Veronika
• Gschwandtner, Michael
• Koppensteiner, Renate
• Steiner, Sabine

Titel

Exercise training increases endothelial progenitor cells and decreases asymmetric dimethylarginine in peripheral arterial disease: A randomized controlled trial

Ist Teil von

• Atherosclerosis, 2011-07, Vol.217 (1), p.240-248

Ort / Verlag

Amsterdam: Elsevier Ireland Ltd

Erscheinungsjahr

2011

Quelle

MEDLINE

Beschreibungen/Notizen

• Abstract Background Supervised exercise training (SET) is recommended as initial treatment to improve walking capacity in peripheral arterial disease (PAD) patients with intermittent claudication. Various mechanisms by which SET yields beneficial effects are postulated, however data regarding its influence on angiogenesis are scarce. Thus, we designed a prospective randomized controlled trial to study the impact of SET on markers of angiogenesis and endothelial function in PAD. Methods Forty PAD patients were randomized to SET on top of best medical treatment (SET + BMT) for 6 months versus best medical treatment (BMT) only. Endothelial progenitor cells (EPC) were assessed by whole-blood flow cytometry (co-expression of CD34+ CD133+ KDR+) and cell culture assays (endothelial cell-colony forming units, circulating angiogenic cells, migration assay) at baseline, 3, 6 and 12-months after inclusion. Changes of plasma levels of asymmetric dimethylarginine (ADMA), vascular endothelial growth factor (VEGF), stromal cell-derived factor-1 (SDF-1) and maximum walking distance were determined. Results EPC – measured by flow cytometric and cell culture techniques – increased significantly upon training paralleled by a significant decrease of ADMA when compared to the BMT group ( p < 0.05). Six months after training cessation, the beneficial effect of SET on EPC diminished, but maximum walking distance was significantly improved compared to baseline and controls ( p < 0.05). No significant changes were observed for VEGF and SDF-1 plasma levels in time course. Conclusions SET increases circulating EPC counts and decreases ADMA levels reflecting enhanced angiogenesis and improved endothelial function, which might contribute to cardiovascular risk reduction.